UNSPSC 51452601: Febantel

This classification denotes an antihelminthic agent with the molecular formula C20H22N4O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S75C401OS1, chemically known as n-(2-(2,3-bis-(methoxycarbonyl)-guanidino)-5-(phenylthio)-phenyl)-2-methoxyacetamide but generally known as febantel, which bears US NIH Compound Identifier 9570638. European Medicines Agency schedules Febantel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07518MIG.

UNSPSC 51452601 Febantel is a Commodity code that maps to state and local pharmaceutical procurement activity, though the recent opportunities tagged under this code show substantial mismatch with its nominal scope. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets — neither of which is febantel. Seminole County, Florida issued an IFB on June 30, 2026, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, also unrelated to febantel. State and local governments sourcing under this code are health departments and county health agencies rather than veterinary or agricultural procurement offices where febantel — an anthelmintic for animal use — would typically be expected.

The recent activity centers on Illinois and Florida, with the Illinois procurement executed through a cooperative purchasing vehicle (MMCAP Infuse) and the Seminole County IFB structured with quarterly deliveries, a two-year initial term plus one-year renewal option, and FEMA-funded compliance requirements. The tagging of two distinct pharmaceutical procurement efforts under a code nominally for febantel suggests either systematic miscoding by the issuing bodies or a broad category interpretation that extends beyond the anthelmintic itself. Neither opportunity is an open solicitation; the Illinois award is closed, and the Seminole County IFB deadline passed in July 2023. No recent open solicitations for febantel itself appear in the available opportunities block.